Search

everythinglearnresearchcommunity

for

Search:↓

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Scalp cooling reduces hair loss and improves quality of life during chemotherapy.

Better supportive care is needed to manage chemotherapy side effects.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Better awareness of chemotherapy's side effects improves self-care.

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

Bimatoprost solution is effective and safe for long-term use in treating eyelash thinning.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

People undergoing chemotherapy need better support and information to cope with hair loss.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.